Naltrexone.
Naltrexone (Trexan R), a long acting, orally affective narcotic antagonist was approved by the Food & Drug Administration in November, 1984 for use as an adjunct in the treatment of Opioid Addiction. This research capsule will explore what is known about naltrexone, and the most appropriate ways of using the drug.
D006801:Humans; D008691:Methadone / Q000627:therapeutic use; D009271:Naltrexone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D010146:Pain / Q000188:drug therapy; D010902:Pituitary Gland / Q000378:metabolism; D011957:Receptors, Opioid / Q000187:drug effects; D013375:Substance Withdrawal Syndrome
D011957:Receptors, Opioid; D009271:Naltrexone; D008691:Methadone